UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 198.127
NA - Nord America 12.501
AS - Asia 4.274
SA - Sud America 675
Continente sconosciuto - Info sul continente non disponibili 407
AF - Africa 122
OC - Oceania 11
Totale 216.117
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 195.716
US - Stati Uniti d'America 12.223
SG - Singapore 1.676
CN - Cina 1.448
SE - Svezia 602
UA - Ucraina 552
BR - Brasile 508
VN - Vietnam 376
DE - Germania 267
GB - Regno Unito 266
FI - Finlandia 220
FR - Francia 216
HK - Hong Kong 185
CA - Canada 148
IN - India 107
KR - Corea 81
BD - Bangladesh 70
AR - Argentina 58
NL - Olanda 56
IQ - Iraq 52
PL - Polonia 48
TR - Turchia 42
MX - Messico 38
AT - Austria 32
JP - Giappone 32
RU - Federazione Russa 32
ES - Italia 31
ZA - Sudafrica 31
PK - Pakistan 28
UZ - Uzbekistan 24
CO - Colombia 22
MA - Marocco 21
ID - Indonesia 20
VE - Venezuela 20
EC - Ecuador 18
JM - Giamaica 18
CL - Cile 17
IL - Israele 17
SA - Arabia Saudita 17
CR - Costa Rica 15
PH - Filippine 15
EG - Egitto 14
IE - Irlanda 14
BE - Belgio 13
CZ - Repubblica Ceca 12
HN - Honduras 12
PY - Paraguay 12
CH - Svizzera 11
KE - Kenya 11
TN - Tunisia 10
TT - Trinidad e Tobago 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
AZ - Azerbaigian 8
LT - Lituania 8
MY - Malesia 8
PE - Perù 8
AU - Australia 7
BO - Bolivia 7
JO - Giordania 7
SC - Seychelles 7
SV - El Salvador 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
IR - Iran 6
NP - Nepal 6
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
PT - Portogallo 5
DZ - Algeria 4
PR - Porto Rico 4
PS - Palestinian Territory 4
TH - Thailandia 4
AL - Albania 3
CI - Costa d'Avorio 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
NZ - Nuova Zelanda 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GD - Grenada 2
GP - Guadalupe 2
GY - Guiana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
MU - Mauritius 2
RS - Serbia 2
SN - Senegal 2
Totale 215.694
Salva come PNG Salva come JPEG
Città #
Cagliari 191.267
Uta 3.837
Ashburn 2.291
Fairfield 915
Singapore 827
San Jose 685
Woodbridge 641
Dallas 458
Chandler 427
Houston 426
Boardman 399
Ann Arbor 383
Seattle 347
Wilmington 341
Nyköping 336
Cambridge 303
Jacksonville 273
Beijing 271
Los Angeles 238
Council Bluffs 235
Dearborn 194
Santa Clara 188
New York 179
Hong Kong 168
Helsinki 137
Shanghai 130
Ho Chi Minh City 119
Hefei 115
Lauterbourg 114
Boston 110
Nanjing 107
Seoul 79
Atlanta 72
Buffalo 72
Hanoi 72
The Dalles 67
San Diego 54
London 53
Orem 52
Milan 51
San Francisco 50
Guangzhou 49
São Paulo 48
Dong Ket 46
Rome 46
Chicago 45
Warsaw 44
Frankfurt am Main 39
Munich 39
Nanchang 39
Denver 38
Columbus 37
Montreal 36
Toronto 33
Brooklyn 32
Hebei 32
Shenyang 32
Phoenix 30
Redwood City 29
Washington 28
Redondo Beach 27
Tianjin 27
Tokyo 27
Baghdad 25
Mountain View 24
Jiaxing 22
Vienna 22
Nuremberg 21
Tashkent 21
Jinan 19
Amsterdam 18
Norwalk 18
Chennai 17
Da Nang 17
Changsha 16
Kunming 16
Johannesburg 15
Mexico City 15
Haiphong 14
Verona 14
Augusta 13
Brussels 13
Dublin 13
Porto Alegre 13
Stockholm 13
Auburn Hills 12
Haverhill 12
Orange 12
Philadelphia 12
San Mateo 12
Sèlegas 12
Cairo 11
Casablanca 11
Miami 11
San José 11
Santiago 11
Taizhou 11
Zhengzhou 11
Brasília 10
Nairobi 10
Totale 208.434
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.788
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 5.168
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.199
Maternal immune activation disrupts dopamine system in the offspring 4.177
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.501
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.423
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.408
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.334
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.072
Pharmacological treatments for nicotine dependence 3.014
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.984
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.843
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.768
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.752
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.627
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.585
null 2.498
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.488
Effects of maternal immune activation on dopamine activity in male and female offspring 2.476
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.405
null 2.394
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.388
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.327
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.258
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.197
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.184
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.164
Trattamenti farmacologici per la dipendenza da nicotina 2.086
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.037
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.021
The role of nuclear hormone receptors in cannabinoid function 1.975
Opposite responses to aversive stimuli in lateral habenula neurons 1.925
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.875
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.872
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.865
Neurobiologia della dipendenza da nicotina 1.834
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.829
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.829
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.828
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.820
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.797
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.789
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.771
Neurobiology of nicotine addiction 1.730
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.681
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.652
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.617
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.615
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.592
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.588
The endocannabinoid system and nondrug rewarding behaviours 1.472
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.464
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.441
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.433
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.421
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.382
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.376
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.357
Neurobiological mechanisms of cannabinoid addiction 1.314
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.284
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.180
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.148
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.136
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.115
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.109
Endocannabinoids and the processing of value-related signals 1.107
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.067
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.063
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.056
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.044
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 1.000
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 969
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 935
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 931
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 877
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 854
null 850
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 848
null 841
From surface to nuclear receptors: the endocannabinoid family extends its assets 830
null 800
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 774
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 772
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 771
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 765
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 750
null 747
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 740
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 735
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 731
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 721
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 673
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 662
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice 660
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 618
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 612
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 611
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 593
A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions 534
"Immuni" and the National Health System: Lessons Learnt from the COVID-19 Digital Contact Tracing in Italy 526
Totale 202.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 278.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 278.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.904 0 0 0 0 1.013 908 564 469 602 1.328 1.738 1.282
2022/202313.833 966 1.337 1.295 1.077 1.299 1.630 730 1.290 1.109 1.039 1.411 650
2023/202449.729 650 566 535 849 1.467 2.427 2.628 1.101 927 889 1.632 36.058
2024/202520.925 3.816 4.750 2.828 2.973 1.635 1.653 1.772 185 396 248 377 292
2025/20269.310 861 442 989 783 660 652 1.659 555 627 1.215 580 287
2026/20274.619 785 1.040 643 2.136 15 0 0 0 0 0 0 0
Totale 216.117